Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial.

Hermsen, Cornelus C; Verhage, Danielle F; Telgt, Denise SC; Teelen, Karina; Bousema, J Teun; Roestenberg, Meta; Bolad, Ahmed; Berzins, Klavs; Corradin, Giampietro; Leroy, Odile; +2 more... Theisen, Michael; Sauerwein, Robert W; (2007) Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial. Vaccine, 25 (15). pp. 2930-2940. ISSN 0264-410X DOI: https://doi.org/10.1016/j.vaccine.2006.06.081

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.vaccine.2006.06.081

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar